Literature DB >> 4102275

Diphosphonates and Page's disease of bone.

R Smith, R G Russell, M Bishop.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4102275     DOI: 10.1016/s0140-6736(71)91447-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  39 in total

Review 1.  Calcitonin and calcitonin receptors: bone and beyond.

Authors:  M Pondel
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

Review 2.  [Introduction to bisphosphonates. History and functional mechanisms].

Authors:  H Fleisch
Journal:  Orthopade       Date:  2007-02       Impact factor: 1.087

Review 3.  The contribution of Sir James Paget (1814-1894) to the study of rheumatic disease.

Authors:  W Buchanan
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

4.  Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

Authors:  M Sato; W Grasser; N Endo; R Akins; H Simmons; D D Thompson; E Golub; G A Rodan
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

5.  Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat.

Authors:  R Schenk; P Eggli; H Fleisch; S Rosini
Journal:  Calcif Tissue Int       Date:  1986-06       Impact factor: 4.333

6.  The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals.

Authors:  A Jung; S Bisaz; H Fleisch
Journal:  Calcif Tissue Res       Date:  1973-03-30

7.  The effect of two diphosphonates on the resorption of mouse calvaria in vitro.

Authors:  J J Reynolds; C Minkin; D B Morgan; D Spycher; H Fleisch
Journal:  Calcif Tissue Res       Date:  1972

Review 8.  Drugs for disorders of bone: pharmacological and clinical considerations.

Authors:  G R Mundy; L G Raisz
Journal:  Drugs       Date:  1974       Impact factor: 9.546

9.  Alendronate blocks TGF-beta1 stimulated collagen 1 degradation by human prostate PC-3 ML cells.

Authors:  M E Stearns
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

Review 10.  Bisphosphonates and the treatment of bone disease in the elderly.

Authors:  A Johansen; M Stone; F Rawlinson
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.